Business

BofA Securities downgrades Sage Therapeutic to 'neutral' with a cost target of $25.00

BofA Securities downgrades Sage Therapeutic to 'neutral' with a cost target of $25.00

Blake

News and digital media editor, writer, and communications specialist. Passionate about social justice, equity, and wellness. Covering the news, viewing it differently.

Related Articles

Back to top button